CX Institutional’s Avanos Medical AVNS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q3 | – | Sell |
-531
| Closed | -$13K | – | 1674 |
|
|
2026
Q2 | $13K | Hold |
531
| – | – | ﹤0.01% | 1248 |
|
|
2026
Q1 | $7K | Hold |
531
| – | – | ﹤0.01% | 1331 |
|
|
2025
Q4 | $6K | Hold |
531
| – | – | ﹤0.01% | 1246 |
|
|
2025
Q3 | $6K | Hold |
531
| – | – | ﹤0.01% | 1245 |
|
|
2025
Q2 | $6K | Hold |
531
| – | – | ﹤0.01% | 1088 |
|
|
2025
Q1 | $8K | Buy |
+531
| New | +$8.29K | ﹤0.01% | 1030 |
|
|
2022
Q3 | – | Sell |
-525
| Closed | -$14K | – | 501 |
|
|
2022
Q2 | $14K | Buy |
+525
| New | +$15.1K | ﹤0.01% | 895 |
|
|
2021
Q4 | – | Sell |
-525
| Closed | -$16K | – | 374 |
|
|
2021
Q3 | $16K | Hold |
525
| – | – | ﹤0.01% | 770 |
|
|
2021
Q2 | $19K | Hold |
525
| – | – | ﹤0.01% | 743 |
|
|
2021
Q1 | $23K | Hold |
525
| – | – | ﹤0.01% | 644 |
|
|
2020
Q4 | $24K | Sell |
525
-6
| -1% | -$250 | ﹤0.01% | 575 |
|
|
2020
Q3 | $18K | Buy |
531
+6
| +1% | +$192 | ﹤0.01% | 563 |
|
|
2020
Q2 | $15K | Hold |
525
| – | – | ﹤0.01% | 498 |
|
|
2020
Q1 | $14K | Hold |
525
| – | – | ﹤0.01% | 418 |
|
|
2019
Q4 | $18K | Hold |
525
| – | – | ﹤0.01% | 355 |
|
|
2019
Q3 | $20K | Sell |
525
-24
| -4% | -$916 | ﹤0.01% | 373 |
|
|
2019
Q2 | $24K | Buy |
549
+24
| +5% | +$1.03K | ﹤0.01% | 382 |
|
|
2019
Q1 | $22K | Sell |
525
-6
| -1% | -$269 | ﹤0.01% | 394 |
|
|
2018
Q4 | $24K | Buy |
+531
| New | +$27.8K | 0.01% | 308 |
|
Other funds holding AVNS
CX Institutional's AVNS Position: Q3 2026 in Review
CX Institutional sold out of Avanos Medical (AVNS) in Q3 2026, closing a stake of 531 shares — an estimated $13K sold.
CX Institutional first reported a position in AVNS in Q4 2018 and held it in 19 quarters. The position peaked at $24K in Q4 2020. 2 funds tracked by Wall St. Rank hold AVNS as of Q3 2026.
- CX Institutional reported no remaining Avanos Medical position as of Q3 2026 after selling out during the quarter.
- CX Institutional sold 531 Avanos Medical shares in Q3 2026, an estimated $13K.
- CX Institutional first reported a position in Avanos Medical in Q4 2018 and held it in 19 quarters.
- CX Institutional's Avanos Medical position peaked at $24K in Q4 2020.
- 2 funds tracked by Wall St. Rank held Avanos Medical as of Q3 2026.
Based on CX Institutional's 13F filing for Q3 2026, filed 2 Oct 2026.